North America Infectious Disease Molecular Diagnostics Market - Size, Share Outlook, Growth Analysis Report and Forecast Trends (2026-2035)

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America Infectious Disease Molecular Diagnostics Market Overview

Infectious Disease Molecular Diagnostics is advancing healthcare by enabling rapid and accurate detection of infectious pathogens through advanced molecular technologies. These diagnostic approaches support early disease identification, treatment decisions, and effective infection control strategies across healthcare settings. The infectious disease molecular diagnostics market in North America is expanding due to rising infectious disease prevalence, technological advancements, increased adoption of rapid testing solutions, and growing healthcare investments. The region benefits from strong diagnostic infrastructure and research activities. The market is poised to reach USD 9.35 Billion by 2035.

North America Infectious Disease Molecular Diagnostics Market Growth Analysis and Key Influencers

North America Infectious Disease Molecular Diagnostics Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

North America Infectious Disease Molecular Diagnostics Market Growth Drivers

Advanced Molecular Testing Technologies to Strengthen the Market Value

The rising adoption of advanced molecular diagnostic technologies is supporting the expansion of the market by improving pathogen detection accuracy and enabling earlier diagnosis. For instance, in April 2026, Boston University researchers reported the development of the ultrasensitive Totally Optimized PCR (TOP) TB assay, which detected previously unidentified tuberculosis DNA in hospitalized patients in the United States. The advancement highlights the growing demand for highly sensitive molecular testing solutions, which is expected to enhance infectious disease diagnosis and accelerate market growth.

North America Infectious Disease Molecular Diagnostics Market Restraints

High Testing Costs and Complex Regulatory Requirements Challenge the Market

High costs associated with molecular diagnostic technologies and complex regulatory approval processes may limit the adoption of advanced testing solutions across healthcare facilities. Expensive instruments, specialized laboratory infrastructure, and the need for skilled professionals can create barriers, particularly for smaller laboratories and resource-limited healthcare settings. These challenges may slow the widespread implementation of innovative molecular diagnostic platforms and affect the overall expansion of the market.

North America Infectious Disease Molecular Diagnostics Market Opportunities

Rising Adoption of Point-of-Care Molecular Diagnostics Can Enhance Market Growth

The increasing demand for rapid, accurate, and minimally invasive diagnostic solutions is creating significant potential for the market. For instance, in December 2025, CARB-X awarded ProtonDx funding to evaluate a blood-based molecular diagnostic approach for identifying pediatric lower-respiratory tract infections using host RNA signatures. The technology aims to support rapid clinical decision-making through portable molecular platforms, reflecting the growing shift toward accessible point-of-care infectious disease testing. Such innovations are expected to create new avenues for market expansion.

North America Infectious Disease Molecular Diagnostics Market Trends

The market is witnessing several trends including point-of-care diagnostics, multiplex testing, and data-driven infectious disease surveillance.

Data-Driven Infectious Disease Surveillance Platforms are Likely to Enhance Market Landscape

The increasing integration of laboratory data analytics with molecular diagnostics is transforming infectious disease monitoring by enabling earlier identification of outbreaks and pathogen trends. For instance, in May 2026, ARUP Laboratories launched a National Infectious Disease Test Positivity Trends Dashboard to track multipathogen positivity patterns using deidentified molecular test results. Such digital surveillance solutions are expected to improve clinical decision-making and strengthen the adoption of advanced molecular diagnostic technologies, supporting market growth.

North America Infectious Disease Molecular Diagnostics Market Share

Polymerase Chain Reaction Segment is Expected to Lead the Market by Technology

The market includes various technologies such as polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing and next generation sequencing, in situ hybridization, DNA microarrays, and others. Among these, polymerase chain reaction technology is expected to lead due to its high sensitivity, accuracy, rapid turnaround time, and widespread clinical adoption. For instance, molecular syndromic panels based on PCR technology enable simultaneous detection of multiple infectious pathogens, improving diagnosis efficiency. According to Thermo Fisher Scientific, multiplex PCR panels help identify multiple respiratory, gastrointestinal, and other infectious agents, supporting faster treatment decisions. The increasing use of PCR-based testing is expected to drive market expansion.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America Infectious Disease Molecular Diagnostics Market Analysis by Region

The regions included in the report are the United States and Canada. Among these, the United States is expected to hold the leading position due to strong healthcare infrastructure, high adoption of advanced diagnostic technologies, and increasing infectious disease surveillance initiatives. According to Centers for Disease Control and Prevention, influenza has resulted in millions of illnesses, hospitalizations, and deaths annually in the United States between 2010 and 2025, highlighting the continuous need for accurate molecular testing solutions. The rising demand for efficient infectious disease detection is expected to support market growth in the region.

Leading Players in the North America Infectious Disease Molecular Diagnostics Market

North America Infectious Disease Molecular Diagnostics Market Segmentation

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Questions Answered in the North America Infectious Disease Molecular Diagnostics Market Report

• What was the North America infectious disease molecular diagnostics market value in 2025?
• What is the North America infectious disease molecular diagnostics market forecast outlook for 2026-2035?
• What are the major factors aiding the North America infectious disease molecular diagnostics market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major North America infectious disease molecular diagnostics market trends?
• Which products and services are expected to dominate the market segment?
• Which type is projected to lead the market segment?
• Which test type is anticipated to drive the market segment?
• Which disease type is likely to dominate the market segment?
• Which technology is expected to dominate the market segment?
• Which end user is projected to lead the market segment?
• Who are the key players involved in the North America infectious disease molecular diagnostics market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a comprehensive mixed-methods research approach combining:

• Primary Research: In-depth interviews conducted with infectious disease specialists, molecular diagnostics experts, laboratory directors, hospital procurement managers, and industry stakeholders across North America, including insights from key opinion leaders associated with organizations such as the Centers for Disease Control and Prevention and National Institutes of Health.
• Secondary Research: Analysis of peer-reviewed publications, clinical studies, regulatory databases from the U.S. Food and Drug Administration, epidemiological data from CDC and NIH, company annual reports, product portfolios, and technology updates from leading diagnostic companies.
• Validation: Market estimates are validated through top-down and bottom-up modeling approaches, data triangulation, and expert feedback loops to ensure accuracy and reliability of market sizing and forecasts.